Verzenio 150 MG tablet UU 14S
Ended Awarded
- Contract number
- SPE2DR26FT692
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,815
Award facts
- Contract value 100% obligated
- $24,815.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,815.18 to AmerisourceBergen Drug Corp for the supply of Verzenio 150 mg tablets (14-count units) under a firm fixed price contract type. This competitive award, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was awarded through open competition.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The broader SPE2DX contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs globally. Verzenio (abemaciclib) is a cancer treatment medication, consistent with AmerisourceBergen's extensive portfolio of brand-name and generic pharmaceutical deliveries through the DLA Medical Supply Chain. The company's selection through open competitive procurement demonstrates its capability to meet federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FT692?
SPE2DR26FT692 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FT692 worth?
The government has obligated $24,815 on SPE2DR26FT692.
Is contract SPE2DR26FT692 an order under another contract?
Yes. SPE2DR26FT692 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT692 competed?
The extent of competition for SPE2DR26FT692 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award